Posted by Michael Wonder on 25 Nov 2016
Agenda for 30 November 2016 TC meeting
24 November 2016 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of romiplostim (Nplate), eltrombopag olamine (Revolade), mifepristone (Miffee), iron isomaltoside (Monover), alglucosidase alfa (Myozyme), house dust mite allergen extract (Acarizax), misoprostol (Misodel) and flutemetamol (F 18) (Vizamyl).
